The brain-derived neurotrophic factor val66met polymorphism and cerebral white matter hyperintensities in late-life depression

American Journal of Geriatric Psychiatry

Volumn 16, Issue 4, 2008, Pages 263-271

  Taylor, Warren D ^a   Zchner, Stephan ^b   McQuoid, Douglas R ^a   Payne, Martha E ^a   MacFall, James R ^a   Steffens, David C ^a   Speer, Marcy C ^a   Krishnan, K Ranga R ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Miami Institute of Human Genomics   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Genetic polymorphisms; Magnetic resonance imaging

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; BRAIN; BRAIN DAMAGE; BRAIN SIZE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GRAY MATTER; HETEROZYGOTE; HOSPITAL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; VAL66MET GENE; WHITE MATTER; AMINO ACID SUBSTITUTION; GENETICS; METHODOLOGY; ONSET AGE; PATHOLOGY;

AGE OF ONSET; AGED; AMINO ACID SUBSTITUTION; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; POLYMORPHISM, SINGLE NUCLEOTIDE; VALINE;

EID: 48649102220     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181591c30     Document Type: Article

References (65)

1. Thomas AJ, O'Brien JT, Davis S, et al: Ischemic basis for deep white matter hyperintensities in major depression. Arch Gen Psychiatry 2002; 59:785-792
2. Thomas AJ, Perry R, Barber R, et al: Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann NY Acad Sci 2002; 977:333-339
3. Tomimoto H, Lin J, Ihara M, et al: Subinsular vascular lesions: An analysis of 119 consecutive autopsied brains. Eur J Neurol 2007; 14:95-101
4. Fujikawa T, Yamawaki S, Touhouda Y: Incidence of silent cerebral infarction in patients with major depression. Stroke 1993; 24:1631-1634
5. Krishnan KRR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry 1997; 154:497-501
6. Krishnan KRR, McDonald WM, Doraiswamy PM, et al: Neuroanatomical substrates of depression in the elderly. Eur Arch Psychiatry Clin Neurosci 1993; 243:41-46
7. Kumar A, Bilker W, Jin Z, et al: Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life depression. Neuropsychopharmacology 2000; 22:264-274
8. de Groot JC, de Leeuw F, Oudkerk M, et al: Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry 2000; 57:1071-1076
9. Figiel GS, Krishnan KRR, Doraiswamy PM, et al: Subcortical hyperintensities on brain magnetic resonance imaging: a comparison between late age onset and early onset elderly depressed subjects. Neurobiol Aging 1991; 12:245-247
10. Lavretsky H, Lesser IM, Wohl M, et al: Relationship of age, age at onset, and sex to depression in older adults. Am J Geriatr Psychiatry 1998; 6:248-256
11. Salloway S, Malloy P, Kohn R, et al: MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 1996; 46:1567-1574
12. Lesser IM, Hill-Gutierrez E, Miller BL, et al: Late-onset depression with white matter lesions. Psychosomatics 1993; 34:364-367
13. Hickie I, Scott E, Mitchell P, et al: Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995; 37:151-160
14. O'Brien J, Ames D, Chiu E, et al: Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ 1998; 317:982-984
15. Simpson S, Talbot PR, Snowden JS, et al: Subcortical vascular disease in elderly patients with treatment resistant depression. J Neurol Neurosurg Psychiatry 1997; 62:196-197
16. Iosifescu DV, Renshaw PF, Lyoo IK, et al: Brain white-matter hyperintensities and treatment outcome in major depressive disorder. Br J Psychiatry 2006; 188:180-185
17. Lavretsky H, Lesser IM, Wohl M, et al: Clinical and neuroradiologic features associated with chronicity in late-life depression. Am J Geriatr Psychiatry 1999; 7:309-316
18. Taylor WD, Steffens DC, MacFall JR, et al: White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry 2003; 60:1090-1096
19. Awad IA, Spetzler RF, Hodak JA, et al: Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke 1986; 17:1084-1089
20. Longstreth WTJ, Manolio TA, Arnold A, et al: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The Cardiovascular Health Study. Stroke 1996; 27:1274-1282
21. Fazekas F, Niederkor K, Schmidt R, et al: White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988; 19:1285-1288
22. Taylor WD, MacFall JR, Payne ME, et al: Greater MRI lesion volumes in elderly depressed subjects than in control subjects. Psychiatry Res 2005; 139:1-7
23. Patankar T, Widjaja E, Chant H, et al: Relationship of deep white matter hyperintensities and cerebral blood flow in severe carotid artery stenosis. Eur J Neurol 2006; 13:10-16
24. Hassan A, Hunt BJ, O'Sullivan M, et al: Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004; 127:212-219
25. Iosifescu DV, Papakostas GI, Lyoo IK, et al: Brain MRI hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (part I). Psychiatry Res 2005; 140:291-299
26. Payne ME, Haines PS, Chambless LE, et al: Food group intake and brain lesions in late-life vascular depression. Int Psychogeriatr 2007; 19:295-305
27. Firbank MJ, Lloyd AJ, Ferrier N, et al: A volumetric study of MRI signal hyperintensities in late-life depression. Am J Geriatr Psychiatry 2004; 12:606-612
28. Takami S, Imai Y, Katsuya T, et al: Gene polymorphism of the renin-angiotensin system associates with risk for lacunar infarction. The Ohasama Study. Am J Hypertens 2000; 13:121-127
29. Schmidt H, Fazekas F, Kostner GM, et al: Angiotensin gene promoter haplotype and microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke 2001; 32:405-412
30. Chen ZY, Patel PD, Sant G, et al: Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 2004; 24:4401-4411
31. Egan MF, Kojima M, Callicott JH, et al: The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112:257-269
32. Pezawas L, Verchinski BA, Mattay VS, et al: The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004; 24:10099-10102
33. Szesko PR, Lipsky R, Mentschel C, et al: Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 2005; 10:631-636
34. Nomura T, Honmou OHK, Houkin K, et al: I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 2005; 136:161-169
35. Yanamoto H, Xue JH, Miyamoto S, et al: Spreading depression induces long-lasting brain protection against infarcted lesion development via BDNF gene-dependent mechanism. Brain Res 2004; 1019:178-188
36. Robins LN, Helzer JE, Croughan J, et al: National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry 1981; 38:381-389
37. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389
38. Taylor WD, Zuchner S, McQuoid DR, et al: Allelic differences in the BDNF val66met polymorphism in late-life depression. Am J Geriatr Psychiatry 2007; 15:850-857
39. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
40. Regier DA, Myers JK, Kramer M, et al: The NIMH Epidemiologic Catchment Area program: historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 1984; 41:934-941
41. Taylor WD, McQuoid DR, Krishnan KR: Medical comorbidity in late-life depression. Int J Geriatr Psychiatry 2004; 19:935-943
42. Rimmler J, McDowell JG, Slotterback BD, et al: Development of a data coordinating center (DCC): data quality control for complex disease studies. Am J Hum Genet 1998; SupplementSuppl 63: A240
43. Byrum CE, MacFall JR, Charles HC, et al: Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation method. Psychiatry Res 1996; 67:215-234
44. Payne ME, Fetzer DL, MacFall JR, et al: Development of a semiautomated method for quantification of MRI gray and white matter lesions in geriatric subjects. Psychiatry Res 2002; 115:63-77
45. Kikinis R, Shenton ME, Gerig G, et al: Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging. J Magn Reson Imaging 1992; 2:619-629
46. Lewis PO, Zaykin D: Genetic Data Analysis 2000. Available at: http://hydrodictyon.eeb.uconn.edu/people/plewis/software.php
47. Weir BS: Genetic Data Analysis II: Methods for Discrete Population Genetic Data. Sunderland, MA, Sinauer Associates, 1996
48. Kumar A, Bilker W, Jin Z, et al: Age of onset of depression and quantitative neuroanatomic measures: absence of specific correlates. Psychiatry Res 1999; 91:101-110
49. Verpillat P, Alperovitch A, Cambien F, et al: Aldosterone synthase (CYP11B2) gene polymorphism and cerebral white matter hyperintensities. Neurology 2001; 56:673-675
50. Webster MJ, Weickert CS, Herman MM, et al: BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Res Dev Brain Res 2002; 139:139-150
51. Shetty AK, Turner DA: In vitro survival and differentiation of neurons derived from epidermal growth factor-responsive postnatal hippocampal stem cells: inducing effects of brain-derived neurotrophic factor. J Neurobiol 1998; 35:395-425
52. Lowenstein DH, Arsenault L: The effects of growth factors on the survival and differentiation of cultured dentate gyrus neurons. J Neurosci 1996; 16:759-769
53. Schwartz ED, Shumsky JS, Wehrli S, et al: Ex vivo MR determined apparent diffusion coefficients correlate with motor recovery mediated by intraspinal transplants of fibroblasts genetically modified to express BDNF. Exp Neurol 2003; 182:49-63
54. Taylor WD, MacFall JR, Provenzale JM, et al: Serial MR imaging of hyperintense white matter lesion volumes in elderly subjects: correlation with vascular risk factors. AJR Am J Roentgenol 2003; 181:571-576
55. Krabbe KS, Nielsen AR, Krogh-Madsen R, et al: Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007; 50:431-438
56. Lee TH, Yang JT, Kato H, et al: Hypertension downregulates the expression of brain-derived neurotrophic factor in the ischemia-vulnerable hippocampal CA1 and cortical areas after carotid artery occlusion. Brain Res 2006; 1116:31-38
57. Baghai TC, Binder EB, Schule C, et al: Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry 2006; 11:1003-1015
58. Bjelland I, Tell GS, Vollset SE, et al: Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: The Hordaland Homocysteine Study. Arch Gen Psychiatry 2003; 60:618-626
59. 66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003; 23:6690-6694
60. Surtees PG, Wainwright NW, Willis-Owen SA, et al: The brain-derived neurotrophic factor Val66Met polymorphism is associated with a sense of coherence in a non-clinical community sample of 7335 adults. J Psychiatr Res 2006; Epub July 25
61. Berton O, McClung CA, DiLeone RJ, et al: Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006; 311:864-868
62. Kaufman J, Yang BZ, Douglas-Palumberi H, et al: Brain-derived neurotrophic factor-5-HTTLPR interactions and environmental modifiers of depression in children. Biol Psychiatry 2006; 59:673-680
63. O'Brien JT, Wiseman R, Burton EJ, et al: Cognitive associations of subcortical white matter lesions in older people. Ann N Y Acad Sci 2002; 977:436-444
64. Whitman GT: A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 2001; 57:990-994
65. Sakakibara R, Hattori T, Uchiyama T, et al: Urinary function in elderly people with and without leukoaraiosis: relation to cognitive and gait function. J Neurol Neurosurg Psychiatry 1999; 67:658-660